TRENTON, N.J.--(BUSINESS WIRE)--BioNJ, New Jersey’s trade association for the biotechnology community, announced today that the third annual Dr. Sol J. Barer Award for Vision, Innovation and Leadership has been awarded to John H. Johnson, President of Global Oncology and Senior Vice President of Eli Lilly and Company. Mr. Johnson was Chief Executive Officer of ImClone Systems prior to the company’s acquisition by Lilly in November 2008.
